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ARTICLE INFO ABSTRACT
In the last decades radiotherapy induced brain injury has become an emerging issue for
physicians. Brain RT-induced injury has been classified, according to its time of onset, into acute,
early delayed, and late forms.  The latter is not reversible. Etiopathogenesys of brain damage after
RT has been at length discussed, vascular injury and white matter pathologic changes have been
described. In our study we described the neurological cognitive and behavioural disruption
produced by radiotherapy in primary brain neoplasia; moreover we demonstrated that the effect of
radiation on the brain has a classic time dependent course, with a severity related to total radiation
dose, individual fraction size, and the volume of brain irradiated. The patients, who suffered from
the consequence of RT, did show slowness of executive functions, and profound alterations of
frontal functions, such as attention focusing, mentation control, analogical judgement and insight,
not differently from those obtained by the patients suffering from subcortical vascular dementia.
The overall result of high dose- RT might be a severely demented, bedridden patient, who “has
been cured” for his primary disease, the brain tumour, but it constrains us to make serious
consideration before radiation therapy onset and in order to implement new strategies to avoid
this damage.
Copyright©2016, Rita Moretti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
Long considered a major concern in pediatric neuro-oncology
(Hall et al., 2004; Spiegler et al., 2004; Byrne, 2005),
treatment-related    neurocognitive sequelae have recently
become increasingly recognized in adult neuro-oncology
(Taphorn et al., 2004; Moretti et al., 2005; Sarkissian, 2005;
Byrne, 2005; O’Neill, 2004).Cranial radiation, used in the
treatment of primary brain tumors, cancer metastatic to brain,
certain head and neck malignancies and historically in the
management of acute leukemia, may result in a debilitating
neurological dysfunction (encephalopathy, headache, seizures,
visual loss, cerebellar toxicity) and cognitive syndrome
(cognitive deficits that include dysfunction of episodic
memory, deficits in speed of information processing and
executive functions such as attention and calculation). (Ruben
et al 2006; Wefel et al., 2004; Taofeek et al., 2014).
Symptoms may be especially accentuated in long-term
survivors of cancer treated with both radiation and
chemotherapy.
*Corresponding author: Rita Moretti,
University of Trieste, Neurological Unit, Trieste, Italy.
All the published reports of severe cognitive impairment in
long-term anaplastic glioma survivors describe patients who
received whole brain RT (usually 4,000-4,500 cGy) plus a
focal tumor boost (Imperato et al., 1980; Barker et al., 2003).
A potentiating effect of nitrosoureas or other chemotherapy on
the neurotoxic effect of RT has been postulated (Klein et al.,
2002; Dropcho, 2003). Following the Radiation Therapy
Oncology Group agreement the maximal tolerated dose for
targets 31–40 mm in diameter should be 15 Gy, and for targets
21–30 mm in diameter, 18 Gy. Anyway data are different
among studies mostly because of the differences in the
definitions of the volume and toxicity, the avoidance of critical
structures, and the type and length of clinical follow-up.
Regarding the fractionated RT, for twice-daily fractionation, a
steep increase in toxicity appears to occur when the
biologically effective dose (BED) is >80 Gy, while for daily
large fraction sizes (>2.5 Gy), the incidence and severity of
toxicity is unpredictable (Murray et al., 1997; Cheung et al.,
2000; Yaacov et al., 2010; Hsiao et al., 2010). Ionising
radiation causes damage by a double-stranded DNA bandage,
by damage to RNA, proteins, lipids and cellular membranes,
by inducing calcium inflow, stimulating apoptosis by
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mechanisms not completely understood (Paleologos, 2000;
Monje and Dietrich, 2012). In the EORTC and Medical
Research Council (MRC), an end to the controversy on the
efficacy of postoperative RT for adult patients with cerebral
LGG was sought in a randomized trial (EORTC 22845/MRC
BR04) that was initiated in 1986. The EORTC Radiotherapy
Cooperative Group, the EORTC Brain Tumor Group, and the
Brain Tumor Working Party of the MRC (UK) participated in
this trial (Karim et al., 2002). This study was planned in the
early 1980s with conventional RT techniques with baseline
clinical and CT scan data. In general, the debate on early post-
operative RT continues and shall continue to dominate the
policy of treatment for some time. The interim results of the
EORTC study indicate the reasons why one group of
specialists does not believe in postoperative early RT and the
believers in RT routinely use early postoperative radiation.
From their personal experience, the nonbelievers in RT find
that the outcome scores of these patients without early
postoperative RT is equally justified, because the hazards of
radiation sequelae from the literature are well known.
Moreover, they consider that delayed RT might be equally
effective.
The series of well conducted studies, in rodents and human
brain exposed to radiotherapy, demonstrated that a particular
area, the so-called subventricular zone (SVZ), might be a
focused target for RT (Monje and Dietrich, 2012; Zhao et al.,
2008; Chang et al., 2000; Dawson et al., 2003; Geha et al.,
2010; Kempermann et al., 1997; Eriksson et al., 1998; Van
Praag et al., 1999). SVZ area maintains a specific role in adult
brain too, throughout the lateral walls of the alteral ventricle:
along with the dentate gyrus of the hippocampus and the
olfactory bulb, the SVZ is one of the three places, where
neurogenesis has been found to occur in the adult mammalian
brain (Quinonones-Hinojosa et al., 2007). Human SVZ stem
cells may contribute to neurogenesis in yet-unknown forebrain
regions, and also may replenish glial precursor populations
throughout the white matter. Oligodendroglial precursor cells
are found throughout white matter and contribute to postnatal
myelination, particularly in the frontal lobes, which do not
complete myelination until the third decade of life. Impairment
of hippocampal neurogenesis may explain the profound
difficulties patients experience encoding new episodic
memories following treatment for brain tumors and other
cancers requiring cranial radiation therapy. Cranial radiation
therapy profoundly inhibits the generation of new hippocampal
granule cell neurons in both rodents and in humans (Monje et
al., 2012). Of note, radiation does not simply ablate the
hippocampal stem and precursor pool, but rather alters the
neurogenic microenvironment. Radiation-induced activation of
local microglia and the subsequent elaboration of pro-
inflammatory cytokines such as interleukin-6 produce a
specific blockade in neuronal differentiation. This micro
environmental perturbation can be mitigated by non-steroidal
anti-inflammatory therapies, offering a possible clinical
intervention for patients suffering from radiation- induced
memory dysfunction (Monje et al., 2002; Monje et al., 2012)
Elsewhere preclinical and clinical evidence showed that
radiation dose received by the neural stem cells of the
subgranular zone in the hippocampus may play a role in
radiation induced neurocognitive decline, specifically memory
recall. Dosimetric capabilities of intensity-modulated
radiotherapy to conformally avoid the hippocampus without
detriment to the radiation dose received by the remainder of
the brain has been detected.
Hippocampal sparing during  whole brain radiotherapy
(WBRT)-largely employed up to ten years ago for brain
lymphomas, for example, may provide a net gain in control
neurocognitive decline (Vinai et al., 2010; Johannesen et al.,
2003; Welzel et al., 2008; Brown et al., 2007; Junie et al.,
2013). Autopsies in a few patients showed diffuse injury to
myelin sheaths with relative preservation of axons and large
blood vessels (De Angelis et al., 1989). The Radiation
Therapy Oncology Group was working on a dose-escalation
study aimed to define the maximal dose for targets of different
sizes; generally the volume of brain receiving ≥12 Gy has been
shown to correlate with both the incidence of radiation
necrosis and asymptomatic radiologic changes and the
presence of comorbid vascular risk factors (e.g., diabetes) (Lee
e t al., 2002; Wong et al., 2004). Radiation-induced brain
injury is described as acute, early delayed, and late delayed
injury (Greene-Schloesser et al., 2012). Between several
different hypotheses of late radiation-induced brain injury the
vascular hypothesis has been strongly described; it seems that
vascular damage leads to ischemia and secondarily to white
matter necrosis.  Vascular structural changes, as vessel wall
thickening, vessel dilation, and endothelial cell nuclear
enlargement have been reported. Similarly, capillary
rarefaction and tissue hypoxia increased after fWBI.  Beside
the vascular hypothesis the parenchymal hypothesis has been
explained involving oligodendrocytes, astrocytes and
microglia role in generating a pro-inflammatory mediators and
subsequent radiation-induced edema (De Angelis et al., 1989;
Vigliani et al., 1999).
The diffuse sufferance of the white matter in radiation induced
neuronal damage is comparable to that seen in subcortical
vascular dementia (Abayomi, 1996). Immunohistochemical
examination of the brains without necrosis found myelin basic
protein-positive fibers were markedly decreased in the affected
areas by irradiation; neurofilament-positive fibers were
moderately decreased and irregularly dispersed in various
shapes in the affected areas, and glial fibrillary acidic proteins-
positive fibers were increased, with gliosis in those areas.
These findings are similar to those in clinically accelerated
brain aging in conditions such as diffuse subcortical ischemia,
previously called Binswanger’s disease. Novel studies have
been done to assess neuroanatomical targets of radiation-
induced cognitive decline. It has been found that regions that
predicted global cognitive outcomes at doses 60 Gy included
the corpus callosum, left frontal white matter, right temporal
lobe, bilateral hippocampi, subventricular zone, and
cerebellum. Regions that did not predict global cognitive
outcomes at any dose include total brain volume, frontal pole,
anterior cingulate, right frontal white matter, and the right
precentralgyrus. (Peiffer et al., 2013). Despite efforts to isolate
cognitive effects due to partial RT alone, prior longitudinal
studies have not consistently controlled for several potential
confounding influences including surgical effects, effects of
underlying disease progression, and practice effects resulting
from serial neuropsychological testing. With these
considerations in mind, the current study evaluated
longitudinal cognitive functioning in the first 12 months
following modern highly conformal fractionated partial brain
RT.  This work is an implementation of that written by our
group (Moretti et al., 2005). We have enrolled 87 new
patients, after having studied 34, described elsewhere (Moretti
et al. 2005). Overall the hypothesis of cognitive decline due to
radiotherapy is interesting, but not unexpected data; however,
the comparison and the items taken into account are for the
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first time compared to those obtained by a group, early-
diagnosed as suffering from subcortical vascular dementia. A
part from the previously employed tests, which we have
reproduced in this work, we have tested more specifically two
distinct aspects apathy and gait and equilibrium. The purpose
is to define and study the potential common frontal white
matter sufferance indirectly determined by radiotherapy, not
deriving from tumor location, but to the involvement of
subcortical networks sufferance, and strictly resembling
subcortical vascular dementia.We present the results after the
12-months follow-up of 87 RT patients.
METHODS
Patients
We have followed 87 cases (51.2 ± 7.3 yrs. old) of primitive
cerebral neoplasia, surgically treated; all of them underwent to
radiotherapy (group A). They were enrolled as admitted in
Neurological Units Section, to be studied and then prepared to
neurosurgery; they were not part of other clinical trials.
Patients were not included in the study if they showed
previous signs of non-lacunar territorial infarcts, normal
pressure hydrocephalus, cortical hemispheric large vessel
strokes or lobar hemorrhages. Patients with previous
psychiatric illness or central nervous system disorders and
alcoholism were also excluded from the study. Patients with
focal Broca or Wernicke’s area brain tumors were also
excluded due to major, confounding linguistic impairment.
Control subjects were 90 men and women, (69.75 ± 2.34 yrs.
old) (group B), entering in Cognitive Disorder Unit Evaluation
of the University of Trieste,  with Mini-Mental State
Examination (MMSE) scores of at least 16 and satisfying the
fourth edition of the Diagnostic and Statistical Manual of
Mental Disorders (DSM-IV) for dementia, recruited from June
1st 2010 to June 1st 2013,  suffering from subcortical vascular
dementia: these study subjects satisfied the criteria for
probable VaD in accordance with the NINDS-AIREN criteria
(Román et al., 1993). A patient was diagnosed as having
subcortical VaD (sVaD) when the CT/MRI scan showed
moderate to severe ischemic white matter changes (Erkinjuntti
et al., 1997) and at least one lacunar infarct. All patients
underwent a standardized baseline assessment that included a
detailed history, a physical examination, laboratory tests and
psychiatric evaluations. Psychiatric evaluations (which later
formed the study’s outcome measures) are described below.
All patients were followed for 12 months, with periodical
examinations. Visits were scheduled to take place 3, 6, and 12
months after the start of treatment. A complete
neuropsychological examination was conducted at baseline,
and at the last visit. The study was conducted in accordance
with the Declaration of Helsinki and with the Ethics
Guidelines of the Institute. Written informed consent was
obtained from all participants or their responsible caregivers
prior to the study.
Outcome measures
Though many works have tried to establish recommendations
fora a core set of neuropsychological tests, common criterion
for defining cognitive impairment and common approaches to
improve the homogeneity of study methods, (Wardy et al.,
2008; Wefel et al., 2011), the purpose of this study suggest us
to implement some other batteries, in order to better define the
frontal and prefrontal executive and behavior functions, and
motor and balance measures. Global cognitive function was
assessed using the MMSE (Folstein et al., 1975) at each visit.
In addition, since the MMSE is not sensitive to changes in
executive functions or mental slowing, attention was assessed
using the number of correct responses in the Digit Span
forward and backward (Wechsler, 1945), the number of
substantives produced in a three-minute task for phonological
and semantic fluency (Wechsler, 1981), and mental and
written calculation (Paradis et al., 1990) and, Apathy Score
(AES-S and C) at each visit (Marin et al., 1991). Behavioural
symptoms were assessed using the Behavioural Pathology in
AD Rating Scale, BEHAVE-AD (Reisberg et al., 1987) at
every visit.  Motor symptoms, concerning gait and equilibrium
have been evaluated by Tinetti scale at each visit (Tinetti et al.,
1996).
Statistical analyses
Statistical analyses were performed using SAS® software
(version 16.0 SAS® Software Inc, Cary, NC, USA). Within-
group changes from baseline were tested using the Wilcoxon
Signed Ranks test. Between-group comparisons of changes
from baseline were tested using the Marginal Homogeneity
Test. Spearmann correlation test has been employed for each
significant variable. This was done for each efficacy variable.
Results are presented as mean changes from baseline with




We have followed 87 cases (51.2 ± 7.3  yrs. old;  + 22.34 at
Briggs and Nebes Test (1975); 14.7 + 3.98 years of school) of
primitive cerebral neoplasia (Group A), surgically
treated/biopsied  and anatomically diagnosed as follows: 17
cerebral lymphomas (mild- or low-grade differentiation), 24
cases of glioblastomamultiforme, 17 cases of grade-2 gliomas,
5 cranyopharingioma, 15 II-III grade-astrocytomas and 9
anaplastic pattern. They underwent to neurosurgery; the
surgical operations have been radical in 29% of cases; 31% of
cases could be considered partially efficacious; 40% of cases
surgery could be considered as a stereotaxical biopsy.  All the
cases in group A were submitted to radiotherapy: the patients
underwent to fractionated external beam radiation therapy
(from 20 to 65 cGy). Three patients had received a
concomitant high-dosage Methotrexate therapy, i.v. and 18
themozolamide orally, concomitantly. We have chosen 90
sVAD patients. All the patients could be fully studied (mean
age 72.3 ± 7.3 years, range= 62-94 years). The diagnosis was
based on historical information and neuropsychological
assessment and supported by findings on structural (CT or
magnetic resonance) imaging. Subsequent follow-up of
subjects has reinforced the clinical diagnoses in all cases.
Brain CT-scans or MRI images were available for all the
selected patients; 90 sVAD patients did CT scans and
moreover, 21 of them completed the diagnostic pathway with
MRI images, in case of not adequate imaging acquisition, or
not convincing data. Therefore, the patients who did CT/MRI
were homogeneously recruited and no demographical/social/
cultural/clinical difference distinguish from each other. A
neurologist (RM) revised all the imaging, employing the
Blennow et al. (1991) scale for CT scans and the Scheltens et
al. (1993) scale for MRI imaging in sVAD patients. There was
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95.8% inter-rater agreement for the independent assessment of
the scans (kappa=0.8).  Patients were allowed to continue any
previous therapy (e.g. antihypertensive, antidyslipidemic,
antidiabetic drugs). During the follow-up, the patients were
prescribed neuroleptics and/or benzodiazepines; nobody has
been prescribed Ache-I or memantine. All the surgery patients
underwent to neuropsychological evaluation; one week before
surgery, one week after surgery, while executing RT, 6 and 12
months after radiotherapy they underwent to
neuropsychological tests. The first two sessions were
dedicated to identify eventual decay of cognitive performances
due to the tumor mass localization or to the brain injury
consequent neurosurgery: patients from Group B attended the
evaluation at the beginning, 6 and 12 months after the
recruitment. At the end of the follow-up process (12.2 + 4.6
months), Group A was composed by:25 patients received a
low dose of radiation (<30 Gy); 18 patients a medium dosage
(30-45 GY) and among this group, 4 subjects died; 44 patients
receive a cumulative dosage of more than 45 Gy up to 65 Gy;
among them 8  subjects died.
The sub-group who received <30 Gy was composed by: 5
cranyopharyngiomas, 11 grade -2 gliomas and 9 astrocytomas
grade 2; the sub-group who received 30-45Gy was composed
by: 6 glioblastomamultiforme, 6 grade - 2 gliomas and 6
astrocytomas grade 2-3; the sub-group who received 45-65Gy
was composed by: 17 lymphomas, 18 glioblastomamultiforme
and 9 anaplastic tumours.  Any patients underwent to WBRT:
radiotherapists used regional fields partial brain, encompasses
each tumor, with an average margin of 2.6 + 0.7 cm from the
initial target tumor volume. Therefore, in this study we have
not considered the size tumor/radiation field ratio. 12  patients
totally died during follow-up and they have been not taken into
account for the final statistical analysis. No patients from
Group B died. Results have been compared within groups
(baseline versus 12 months follow-up) and between groups
(low vs medium vs high dosage of radiation, and vs control
group).
At baseline, patients in group B did worse than those of group
A in semantic fluency, in analogies tasks and in the digit span
forward/backward task (p<0.05). There was no significant
difference in mental calculation, apathy and in behavior (see
Table 1). Afterwards, we examined the results which have
been summarized in Table 2, 3 and 4 and proceed by
comparison between groups (Group A, divided by total dose,
vs B at baseline; Group A divided by total dose at 12 months,
versus baseline by Wilcoxon Signed rank test within group;
Group B at 12 months, versus baseline by Wilcoxon Signed
rank test within group; lastly, there is the differences between
Groups at 12 months by Wilcoxon Signed Rank Test). 26
patients who received a cumulative dose of radiation <30 cGy
did show specific differences when compared with sVAD, in
phonological and semantic fluency, analogies, digit span
backward, apathy at baseline (Table 2); at 12 months,  but they
did not show significant differences with baseline results, a
part from a dramatic increase in apathy scores (as showed in
Table 2 Group A got worse in semantic fluencies, analogies,
apathy and Tinetti total scores); when compared at 12 months
Group B did worse than A in phonological, semantic,
analogies, Digit span Forward, apathy in Tinetti equilibrium,
gait and total scores. 30 patients who received a total dose
comprised between 30-45 cGy manifested a global slowness of
cognitive process. Before the beginning of RT, they did worse
than sVAD in mental calculation, analogies digit span
backwards, apathy between groups, table 3, and second row).
They dramatically deteriorated in all the tasks a part from digit
span and backwards (within groups at 12 months, table 3, third
row). They did worse than sVad after 12 months (between
groups, table 3, 5th row) in MMSE, in fluency tasks, in
analogies, in apathy scores. All the patients, in both group
showed an evident deterioration of walking strategies,
evidenced by a patent disequilibrium, and gait alterations
(significantly different within groups baseline vs 12months),
not different between groups. 20 patients who underwent to
high doses of radiotherapy (45 Gy-65 Gy) presented at
baseline worse performances in all the items between groups
(RT vs SVAD, 2nd row, Table 4). At 12 months they
decreased their performances significantly (within groups, 3rd
row, table 4); between groups at 12 months revealed more
profound deterioration in RT patients than in sVAD in all the
performances, more profoundly in apathy and gait scores. All
the oncological patients underwent to MRI scans, after RT; the
increase of white matter alterations, defined by white matter
hyperintensity on the T2-weighted images, markedly on the
periventricular regions was markedly evident from the 30-45
up to 45-65 Gy; in the last group, white matter hyperintesities
on the T2 weighted images interested
frontal subcortical areas and profoundly para-ventricular
frontal areas. When compared between groups, we divided the
process into three subitems: <30 Gyvs 30-45 and vs 45-65, and
30-45 vs 45-65 Gy (Table 5). When considering a marginal
homogeneity test: The first subitem comprises the following
results: MMSE average scores, phonological fluency, mental
calculation, analogies, apathy were worse (mean MH statistics
498,00± 3.46; 663,00± 5.47; 562,00± 3.107; 633,00± 2.1;
612,00± 1.47, respectively, all p<0.01) than those of 30-45 Gy.
Semantic fluency and digit forward were worse (mean MH
statistics 562,00± 3.107 and 453,00± 5.47, respectively
p<0.05); not significant the digit backward and BEHAVE
Table 1. A synopsis of the scores obtained by the two groups at baseline group A, before RT;
Apathy scores, AES-C, clinician rated apathy evaluation scale; AES-S, self-report rated apathy evaluation scale.
Values are mean (SD). NS=not significant
Tests Group A (before RT) Group B (sVAD)
MMSE 28.34 ± 2.23 27.34 ± 2.34ns
Phon. Fluency (items produced) 45.67 ± 2.45 39.34 ± 3.56 ns
Sem. Fluency (items produced) 32.16 ± 2.56 27.34 ± 2.34 *
Mental calculation (correct /15) 11.4 ± 2.34 9.87 ± 1.34 ns
Analogies (correct/26) 24.56 ± 5.67 19.34 ± 2.45 *
Digit span forward 6.78 ± 2.34 4.56 ± 2.13*
Digit span backward 5.97 ± 1.23 4.03 ± 1.23*
BEHAVE-AD 4.56 ± 7.67 3.7 ± 0.34
AES-S 10.5 ± 1.1 12.1 ± 5.3
AES-C 7.22 ± 2.1 15. 9 ± 1.2
p<0.05 vs RT group; ** p<0.01 vs RT group
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complete score; a slight significant difference comes evident in
Tinetti gait, equilibrium and total score. The second subitem
comprises a statistical significance (p<0.001) in all the scores.
The third subitem comprises the following results: MMSE
average scores, phonological   and semantic fluency, mental
calculation, analogies, digit backwards, apathy were worse
Table 2. A synopsis of the scores obtained by the patients of group A, who underwent to a total dose < 30cGy, at 12 month
Tests Group A (RT)
<30Gy




A vs B 12
months
MMSE 25.9 ± 1.7 26.34 ± 2.2 - 1.7 ± 2.1 -1.14 ± 2.1 -0.3 ± 1.0 NS
Phon. Fluency (items prod.) 40.1 ± 2.2 31.67 ± 2.4 * -5.9 ± 2.4 -6.9 ± 2.4 ** -8.3 ± 1.4 **
Sem. Fluency (items prod) 34.5 ± 1.23 24.4 ± 1.4* -5.4 ± 2.1* -2.1 ± 6.4* - 7.1 ± 1.4 **
Mental calculation (correct /15) 12.3 ± 1.4 11.8 ± 1.3 - 1.8 ± 1.3 ns -0.87 ± 1.34 ns -1.3 ± 1.1 NS
Analogies (correct/26) 19.2 ± 1.1 24.5± 5.6 * - 1.6 ± 2.7 * -3.56 ± 5.67 * -6.3 ± 1.4 **
Digit span forward 6.7 ± 0.4 6.8 ± 2.3 ns - 1.6 ± 2.13 ns -1.56 ± 2.13 ns -0.3 ± 0.1 **
Digit span backward 4.65 ± 0.7 6.1 ± 0.3 * -0.3 ± 1.23 ns -1.1 ± 0.2 ns -0.7 ± 0.4 NS
BEHAVE-AD 3.1 ± 1.4 2.7 ± 0.4 ns +1.7 ± 0.4 ns +2.7 ± 0.3 ns -0.8 ± 1.4 NS
AES-S 9.5 ± 1.4 12.1± 0.4** +2.1 ± 0.4* +6.1 ± 0.4** +8.3 ± 1.2 **
AES-C 12.1 ± 1.4 15.9 ± 4.34 ** +5.1 ± 1.2 ** +7.1 ± 1.2 ** -7.3 ± 1.1 **
TINETTI equilibrium 13.1 ± 0.1 10.1 ± 0.1 -1.1 ± 0.5 ns -3 ± 0.6  ** -4.3 ± 1.1 **
TINETTI gait 10.2 ± 1.1 10.2 ± 1.1 -1.2 ± 1.1 ns -4.9 ± 1.1  ** -6.1 ± 1.4 **
TINETTI tot.score 23.3 ± 1.2 20.3 ± 1.2 -3.3 ± 1.6 * -7.9 ± 0.2  ** -11.2 ± 1.4 **
Table 3. A synopsis of the scores obtained by the patients of group A, who underwent to a total dose 30-45Gy, at 12 month








A vs B 12
mths
MMSE 26.3 ± 1.2 26.34 ± 2.2 -4.64 ± 2.1 ** -1.14 ± 2.1 -2.3 ± 1.4 **
Phon. Fluency (items prod.) 29.3 ± 2.6 31.67 ± 2.4 -7.9 ± 2.4 ** -6.9 ± 2.4 ** -2.3 ± 1.4 *
Sem. Fluency (items prod) 26.7 ± 2.9 24.4 ± 1.4 -11.4 ± 5.4** -2.1 ± 6.4* - 7.1 ± 1.4 **
Mental calculation (correct /15) 6.7 ± 1.2 11.8 ± 1.3 ** -3.7 ± 1.4 * -0.7 ± 1.4 ns -1.3 ± 1.1 NS
Analogies (correct/26) 17.9 ± 4.1 24.5± 5.6 ** -6.6 ± 5.7 ** -3.56 ± 5.67 * -9.4 ± 1.4 **
Digit span forward 4.9 ± 1.4 6.8 ± 2.3 ns -1.6 ± 2.1 ns -1.7 ± 2.1 ns -1.6 ± 0.1 NS
Digit span backward 4.1 ± 2.2 6.1 ± 0.3 * -2.1 ± 1.23 ns -1.1 ± 0.2 ns -0.7 ± 0.4 NS
BEHAVE-AD 5.84 ± 3.89 2.7 ± 0.4 ns +2.9 ± 0.4 ns +2.7 ± 0.3 ns -2.8 ± 1.4 NS
AES-S 19.4 ± 1.4 12.1± 0.4** +8.1 ± 0.4** +6.1 ± 0.4** -7.3 ± 1.2 **
AES-C 21.5 ± 1.4 15.9 ± 4.34 ** +9.3 ± 1.2 ** +7.1 ± 1.2 ** -8.3 ± 1.1 **
TINETTI equilibrium 12.4 ± 0.2 10.1 ± 0.1 -3.1 ± 0.3 ** -3 ± 0.6  ** 0.3 ± 1.1 NS
TINETTI gait 10.8 ± 0.7 10.2 ± 1.1 -3.3 ± 0.7** -4.9 ± 1.1  ** -0.4 ± 0.4 NS
TINETTI tot.score 23.2 ± 0.3 20.3 ± 1.2 -8.3 ± 1** -7.9 ± 0.2  ** -0.5 ± 0.4 NS
* p<0.05 vs baseline; ** p<0.01 vs baseline;
Table 4. A synopsis of the scores obtained by the patients of group A who underwent to a total dose 45-65 Gy, at 12 month








A vs B 12 mths
MMSE 19.0 ± 2.7 26.34 ± 2.2** -6.4 ± 1.1 ** -1.1 ± 2.1 -6.3 ± 1.4 **
Phon. Fluency (items prod.) 14.5 ± 1.7 31.67 ± 2.4 * -7.9 ± 2.4 ** -6.9 ± 2.4 ** -15.3 ± 1.1*
Sem. Fluency (items prod) 13.2 ± 1.5 24.4 ± 1.4* -4.4 ± 5.4** -2.1 ± 6.4* - 6.5 ± 1.4 **
Mental calculation (correct /15) 4.1 ± 0.2 11.8 ± 1.3 ** -2.7 ± 1.4 * -0.7 ± 1.4 ns -4.3 ± 1.1**
Analogies (correct/26) 12.2 ± 0.6 24.5± 5.6 ** -6.6 ± 5.7 ** -3.56 ± 5.67 * -9.7 ± 1.4 **
Digit span forward 4.0 ± 0.8 6.8 ± 2.3* -1.6 ± 2.1 * -1.7 ± 2.1 ns -3.6 ± 0.1 **
Digit span backward 3.6 ± 0.3 6.1 ± 0.3 * -2.3 ± 1.2* -1.1 ± 0.2 ns -3.4 ± 0.4 **
BEHAVE-AD 5.7 ± 4.7 2.7 ± 0.4  * +2.9 ± 0.4 * +2.7 ± 0.3 ns +6.8 ± 1.4 **
AES-S 21.8 ± 3.4 12.1± 0.4** +18.1 ± 0.4** +6.1 ± 0.4** +24.3 ± 1.2 **
AES-C 25.2 ± 2.2 15.9 ± 4.34 ** +19.3 ± 1.2 ** +7.1 ± 1.2 ** +25.3 ± 1.1 **
TINETTI equilibrium 9.1 ± 0.1 10.1 ± 0.1 -3.1 ± 0.3 ** -3 ± 0.6  ** -0.6 ± 1.1 *
TINETTI gait 7.2 ± 1.4 10.2 ± 1.1* -5.3 ± 0.7** -4.9 ± 1.1  ** -0.4 ± 0.4 *
TINETTI tot.score 15.3 ± 1.5 20.3 ± 1.2** -8.4 ± 1** -7.9 ± 0.2  ** -0.5 ± 0.4*
* p<0.05 vs baseline; ** p<0.01 vs baseline
Table 5. A synopsis of the scores obtained by the three groups of RT patients at 12 month
Tests Group A (RT) <30Gy Group A 30-45 Gy Group A 45-65 Gy
MMSE 24.2 ± 1.6 **; §§ 21.3 ± 1.2 §§ 12.1 ± 2.7
Phon. Fluency 35.2 ± 2.2 **; §§ 19.7 ± 2.6 §§ 7.5 ± 1.7
Sem. Fluency (items produced) 29.1 ± 1.3 *;§§ 15.3 ± 2.9 §§ 9.2 ± 1.5
Mental calculation (correct /15) 10.5 ± 1.4 **; §§ 3.0 ± 1.2 §§ 2.3 ± 0.2
Analogies (correct/26) 18.6 ± 1.1 **; §§ 1.1 ± 4.1 §§ 6.2 ± 0.6
Digit span forward 5.1 ± 0.4 *; §§ 3.3± 1.4  ns 2.7 ± 0.8
Digit span backward 4.3 ± 0.7 ns; §§ 2.0 ± 2.2 §§ 1.6 ± 0.3
BEHAVE-AD 4.8 ± 1.4 ns; §§ 8.7 ± 3.8 ns 9.6 ± 4.5
AES-S 12.6 ± 1.4 **; §§ 27.5 ± 1.4 §§ 39.8 ± 3.4
AES-C 17.2 ± 1.4 **; §§ 30.8 ± 1.4 §§ 45.2 ± 2.2
TINETTI equilibrium 12.0 ± 0.1*;§§ 9.13 ± 0.4 §§ 6.1 ± 0.8
TINETTI gait 9.2 ± 1.1*;§§ 7.5 ± 1.2 §§ 2.2 ± 1.1
TINETTI tot.score 21.2 ± 1.2*;§§ 16.38 ± 1.3 §§ 8.4 ± 1.2
* p<0.05 vs 30-45; ** p<0.01 vs 30-45; ns not significant
§p<0.05 vs  45-65;  §§ p<0.01 45-65; ns not significant
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(mean MH statistics 458,00± 3.46; 663,00± 5.47; 562,00±
3.107; 633,00± 2.1; 756,00± 2.56, 896,00± 1.36, 1126,00±
12.6 , respectively, p<0.001). BEHAVE and digit forward
were not significantly worse. Tinetti gait and equilibrium were
worse (mean MH statistics 658,00± 3.46; 867,00± 5.47;
656,00± 3.107; 633,00± 2.1; 756,00± 2.56, 896,00± 1.36,
1126,00± 12.6 , respectively, p<0.001). 12 patients who
received oral chemotherapy and average dosage of 45-65 Gy
manifested gradually onset gait apraxia, severe enough to
prevent ambulation, and urinary incontinence, with total loss
of insight and awareness, and were bed-ridden at the end of the
follow-up.
DISCUSSION
Our study demonstrated that there is a significant global effect
of radiation on the brain; either on tumor survival either on
global function decline. These effects have a time dependent
course, severely related to the total radiation dose, even if we
have not determined the size tumor/radiation field ratio (Valk
et al., 1991). All the patients with a total radiation does <35
cGy did not show any sign of cognitive impairment, apart from
those determined by the tumor and by the surgical
consequence. On the other hand, all the patients with a total
irradiation dose < 45 cGy did show profound cognitive and
behavioural alteration, more evident than those manifested by
a matched group of patients suffering from subcortical
vascular dementia from more than 12 months. The patients
who received a total dose of brain radiation comprised
between 35-45 cGy did show slowness of executive functions,
and profound alterations of frontal functions, such as attention
focusing, mentation control, analogical judgement and insight;
all the scores obtained in specific tasks did not differ from
those obtained by the patients suffering from subcortical
vascular dementia. Moreover, all the patients presented overt
apathy and evident alterations, much more significant in those
receiving more than 30 Gy or total radiation, on gait and
balance. The modality of altered impairment is very similar to
that seen and described in sVAD: very dramatically
demonstrated by executive dysfunctions,apathy, gait
alterations, and disequilibrium. What it has been observed in
our study is that higher dosage of RT dramatically involved
brain subcortical networks, even distant from the tumor
location with a significant worsening, more rapid than the
normally presented by sVAD patients.
Data from literature have been investigate, showing that older
age was associated with poorer performances on all cognitive
measures (Vigliani et al., 1996), with better performances in
individuals with more education and younger, in our study
brain radiated injury was directly related to the volume of
brain treated with radiotherapy, not with age (lower in our
group) and not with educational level (higher in our group).
Our hypothesis to explain cognitive disruption due to RT may
be evoked by the severe impairment of the cortical-subcortical
frontal loops, which integrate and process the flow of
information from the cortical areas, where cognition is
“elaborated” and prepared, towards the thalamus, subthalamus
and cerebellum, where it is continuously refined and executed
(Metha, 2000; Hoang-Xuan et al., 1997). Therefore, it might
be concluded that subcortical lesions, per se, cause imbalance
and gait alteration: we might hypothesize that these subcortical
hypoperfusion might interrupt long loop reflexes of deep white
motor tracts and descending motor fibres arising from medial
cortical areas, probably related to SVZ cells alterations  (see
data and literature in: Guerini et al., 2008; Moretti et al., 2009:
Monje et al., 2012); moreover, subcortical vascular lesions
interest fibres connecting frontal cortex and subcortical
structures, which are responsible for motivation, executive
function, planning and attention too (see in particular frontal
eye fields). It has been suggested (see data and Literature in
Moretti et al., 2009; Monje et al., 2012) that the basal ganglia
maintains cortically selected motor set in the supplementary
motor area and provides internal cues to the supplementary
motor area in order to enable each sub movement to be
correctly linked together (Iansek et al. 1995; Lee et al., 1999;
Almeida et al., 2005; Gurvich et al., 2007). Cerebral atrophy
with diffuse demyelination and spongiform changes in the
white matter are seen pathologically (Posner, 1995).
This typical disposition make clear of the cognitive and
behavioural subcortical frontal and white matter alterations,
observed in our patients. Starting from the perspective that the
neurocognitive sequelae of cranial irradiation can be seen to be
mediated through vascular injury, resulting in ischemia and
hypoxia in subcortical areas and in the hippocampal region,
and that pathologic changes are most profound in the white
matter where a heterogeneous necrosis can be encountered, we
compared the results produced by a group of patients treated
by radiotherapy and those similar to those manifested by
patients suffering from subcortical vascular dementia (see data
and literature in  Vinai et al., 2010). The number of cancer
survivors is still growing and long term complications after
cancer treatment are becoming a serious problem for the
society. However, radiotherapy might be indispensable for a
“quoadvitam” discrete prognosis in specific and well selected
cases, but it can be a potential causative factor of evident
cognitive disruption. Consequent problems for a
“quoadvaletudinem” prognosis, especially in young patients,
with low-grade, late-progressing brain tumours must be taken
into account, when considering the personal flow chart after
the diagnosis of brain tumors. Treatment of cognitive sequelae
after cerebral radiation remains very limited, more
understanding about the underlying pathophysiology of RT
induced vasculopathy is needed to develop preventive
strategies (Brown et al., 2013).
Notes: the Authors thanks Claudio Tiribelli MD, PhD, for his
helpfully assistance and for his precious advices during the
revision of the manuscript.
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